Lisata appoints veteran biopharma CFO Farrow to Board of Directors
Lisata Therapeutics announced the appointment of Jeffrey Farrow, a veteran CFO, to its Board of Directors effective October 13. The move strengthens the Board during the clinical development of its lead pipeline candidates.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed